Page last updated: 2024-10-17

lactic acid and Experimental Mammary Neoplasms

lactic acid has been researched along with Experimental Mammary Neoplasms in 38 studies

Lactic Acid: A normal intermediate in the fermentation (oxidation, metabolism) of sugar. The concentrated form is used internally to prevent gastrointestinal fermentation. (From Stedman, 26th ed)
2-hydroxypropanoic acid : A 2-hydroxy monocarboxylic acid that is propanoic acid in which one of the alpha-hydrogens is replaced by a hydroxy group.

Research Excerpts

ExcerptRelevanceReference
"The mechanisms underlying breast cancer chemoprevention by WA were elucidated by immunoblotting, biochemical assays, immunohistochemistry, and cytokine profiling using plasma and tumors from the MNU-rat (n = 8-12 for control group, n = 7-11 for 4 mg/kg group, and n = 8-12 for 8 mg/kg group) and/or mouse mammary tumor virus-neu (MMTV-neu) models (n = 4-11 for control group and n = 4-21 for 4 mg/kg group)."5.46Disease Subtype-Independent Biomarkers of Breast Cancer Chemoprevention by the Ayurvedic Medicine Phytochemical Withaferin A. ( Beumer, JH; Christner, SM; Davidson, NE; Hahm, ER; Kim, SH; Pore, SK; Roy, R; Samanta, SK; Sehrawat, A; Shuai, Y; Singh, KB; Singh, SV, 2017)
" Under conditions of acute hypoxia induced by breathing carbon monoxide at 660 ppm, the apparent glycolytic rate was 0."3.71Effect of changing tumor oxygenation on glycolytic metabolism in a murine C3H mammary carcinoma assessed by in vivo nuclear magnetic resonance spectroscopy. ( Bentzen, L; Daugaard, P; Horsman, MR; Maxwell, RJ; Nielsen, FU; Overgaard, J; Stødkilde-Jørgensen, H, 2001)
"However, its role in breast cancer cell glucose metabolism was unclear."1.62Anti-Warburg effect by targeting HRD1-PFKP pathway may inhibit breast cancer progression. ( Fan, Y; Jin, F; Liang, X; Song, T; Su, D; Wang, J; Wang, Y; Xu, Y, 2021)
"4T1 murine breast cancer cells were transfected with shRNA plasmids directed against LDH-A (KD) or a scrambled control plasmid (NC)."1.48LDH-A regulates the tumor microenvironment via HIF-signaling and modulates the immune response. ( Blasberg, R; Cohen, IJ; Khanin, R; Koutcher, JA; Maeda, M; Mane, M; Moroz, E; Satagopan, J; Serganova, I; Shindo, M; Vemuri, K, 2018)
"The mechanisms underlying breast cancer chemoprevention by WA were elucidated by immunoblotting, biochemical assays, immunohistochemistry, and cytokine profiling using plasma and tumors from the MNU-rat (n = 8-12 for control group, n = 7-11 for 4 mg/kg group, and n = 8-12 for 8 mg/kg group) and/or mouse mammary tumor virus-neu (MMTV-neu) models (n = 4-11 for control group and n = 4-21 for 4 mg/kg group)."1.46Disease Subtype-Independent Biomarkers of Breast Cancer Chemoprevention by the Ayurvedic Medicine Phytochemical Withaferin A. ( Beumer, JH; Christner, SM; Davidson, NE; Hahm, ER; Kim, SH; Pore, SK; Roy, R; Samanta, SK; Sehrawat, A; Shuai, Y; Singh, KB; Singh, SV, 2017)
" Sustained release nanoparticles (NP) offer increased resistance to nuclease degradation, increased amounts of AS uptake, and the possibility of control in dosing and sustained duration of AS administration."1.36Biodistribution of antisense nanoparticles in mammary carcinoma rat model. ( Adwan, H; Berger, MR; Elazar, V; Golomb, G; Lifshitz-Shovali, R; Rohekar, K; Zepp, M, 2010)

Research

Studies (38)

TimeframeStudies, this research(%)All Research%
pre-19902 (5.26)18.7374
1990's8 (21.05)18.2507
2000's9 (23.68)29.6817
2010's18 (47.37)24.3611
2020's1 (2.63)2.80

Authors

AuthorsStudies
Fan, Y1
Wang, J2
Xu, Y1
Wang, Y1
Song, T1
Liang, X1
Jin, F1
Su, D1
Ben David-Naim, M1
Grad, E1
Aizik, G1
Nordling-David, MM1
Moshel, O1
Granot, Z1
Golomb, G2
Peng, Y1
Nie, J1
Cheng, W1
Liu, G1
Zhu, D1
Zhang, L1
Liang, C1
Mei, L1
Huang, L1
Zeng, X1
Serganova, I1
Cohen, IJ1
Vemuri, K1
Shindo, M1
Maeda, M1
Mane, M1
Moroz, E1
Khanin, R1
Satagopan, J1
Koutcher, JA1
Blasberg, R1
Türkcan, S1
Kiru, L1
Naczynski, DJ1
Sasportas, LS1
Pratx, G1
Cox, BL1
Erickson-Bhatt, S1
Szulczewski, JM1
Squirrell, JM1
Ludwig, KD1
Macdonald, EB1
Swader, R1
Ponik, SM1
Eliceiri, KW1
Fain, SB1
Zhao, T1
Zhu, Y1
Morinibu, A1
Kobayashi, M1
Shinomiya, K1
Itasaka, S1
Yoshimura, M1
Guo, G1
Hiraoka, M1
Harada, H1
Sepehri, N1
Rouhani, H1
Tavassolian, F1
Montazeri, H1
Khoshayand, MR1
Ghahremani, MH1
Ostad, SN1
Atyabi, F1
Dinarvand, R1
Shchepin, RV1
Pham, W1
Chekmenev, EY1
Gross, BP1
Wongrakpanich, A1
Francis, MB1
Salem, AK1
Norian, LA1
Iversen, AB1
Ringgaard, S1
Laustsen, C1
Stødkilde-Jørgensen, H3
Bentzen, L2
Busk, M1
Horsman, MR3
Samanta, SK1
Sehrawat, A1
Kim, SH1
Hahm, ER1
Shuai, Y1
Roy, R1
Pore, SK1
Singh, KB1
Christner, SM1
Beumer, JH1
Davidson, NE1
Singh, SV1
Chen, P1
Zuo, H1
Xiong, H1
Kolar, MJ1
Chu, Q1
Saghatelian, A1
Siegwart, DJ1
Wan, Y1
Mohammadi, Z1
Sharif Zak, M1
Seidi, K1
Barati, M1
Akbarzadeh, A1
Zarghami, N1
Sabel, MS1
Su, G1
Griffith, KA1
Chang, AE1
Elazar, V1
Adwan, H1
Rohekar, K1
Zepp, M1
Lifshitz-Shovali, R1
Berger, MR1
Kersey, FR1
Zhang, G1
Palmer, GM1
Dewhirst, MW4
Fraser, CL1
Balliet, RM1
Capparelli, C1
Guido, C1
Pestell, TG1
Martinez-Outschoorn, UE1
Lin, Z1
Whitaker-Menezes, D1
Chiavarina, B1
Pestell, RG1
Howell, A1
Sotgia, F1
Lisanti, MP1
Magnitsky, S1
Belka, GK1
Sterner, C1
Pickup, S1
Chodosh, LA1
Glickson, JD2
Lee, ES1
Na, K1
Bae, YH1
Schroeder, T2
Yuan, H1
Viglianti, BL1
Peltz, C2
Asopa, S1
Vujaskovic, Z1
Rajkumar, L1
Balasubramanian, K1
Arunakaran, J1
Govindarajulu, P1
Srinivasan, N1
Fantin, VR1
St-Pierre, J1
Leder, P1
Wang, P1
Jia, L1
Sanders, BG1
Kline, K1
Shrieve, DC1
Deen, DF1
Harris, JW1
Allémann, E2
Brasseur, N2
Benrezzak, O1
Rousseau, J2
Kudrevich, SV2
Boyle, RW1
Leroux, JC1
Gurny, R1
Van Lier, JE2
Tamulevicius, P1
Streffer, C1
He, Q1
Shungu, DC1
van Zijl, PC1
Bhujwalla, ZM1
Stubbs, M1
Rodrigues, L1
Howe, FA1
Jeong, KS1
Veech, RL1
Griffiths, JR1
Labrie, F1
Li, S1
Bélanger, A1
Côté, J1
Mérand, Y1
Lepage, M1
Lewis, K1
Nielsen, FU2
Topp, S1
Overgaard, J2
Maxwell, RJ2
Ehrhart, N1
Dernell, WS2
Ehrhart, EJ1
Hutchison, JM1
Douple, EB1
Brekke, JH2
Straw, RC1
Withrow, SJ2
Daugaard, P1
Walenta, S2
Snyder, S1
Haroon, ZA1
Braun, RD1
Amin, K1
Brizel, D1
Mueller-Klieser, W2
Chance, B1
Morello, E1
Kuntz, CA1
LaRue, SM1
Lafferty, M1
Nelson, A1
Mallinckrodt, CH1
Manning, MC1
Paschen, W1
Kallinowski, F1
Vaupel, P1

Other Studies

38 other studies available for lactic acid and Experimental Mammary Neoplasms

ArticleYear
Anti-Warburg effect by targeting HRD1-PFKP pathway may inhibit breast cancer progression.
    Cell communication and signaling : CCS, 2021, 02-15, Volume: 19, Issue:1

    Topics: Adenosine Triphosphate; Animals; Breast Neoplasms; Cell Line; Cell Movement; Cell Proliferation; Dis

2021
Polymeric nanoparticles of siRNA prepared by a double-emulsion solvent-diffusion technique: Physicochemical properties, toxicity, biodistribution and efficacy in a mammary carcinoma mice model.
    Biomaterials, 2017, Volume: 145

    Topics: Animals; Cell Death; Cell Line, Tumor; Cell Proliferation; Diffusion; Disease Models, Animal; Emulsi

2017
A multifunctional nanoplatform for cancer chemo-photothermal synergistic therapy and overcoming multidrug resistance.
    Biomaterials science, 2018, May-01, Volume: 6, Issue:5

    Topics: Animals; Antineoplastic Agents; Docetaxel; Dopamine; Drug Liberation; Drug Resistance, Neoplasm; Fem

2018
LDH-A regulates the tumor microenvironment via HIF-signaling and modulates the immune response.
    PloS one, 2018, Volume: 13, Issue:9

    Topics: Animals; Breast Neoplasms; Cell Line, Tumor; Female; Gene Knockdown Techniques; Humans; Hypoxia-Indu

2018
Lactic Acid Accumulation in the Tumor Microenvironment Suppresses
    Cancer research, 2019, 01-15, Volume: 79, Issue:2

    Topics: Animals; Breast Neoplasms; Cell Hypoxia; Cell Line, Tumor; Cell Proliferation; Female; Fluorodeoxygl

2019
A novel bioreactor for combined magnetic resonance spectroscopy and optical imaging of metabolism in 3D cell cultures.
    Magnetic resonance in medicine, 2019, Volume: 81, Issue:5

    Topics: Animals; Bioreactors; Cell Line, Tumor; Cell Survival; Collagen; Contrast Media; Diffusion; Disease

2019
HIF-1-mediated metabolic reprogramming reduces ROS levels and facilitates the metastatic colonization of cancers in lungs.
    Scientific reports, 2014, Jan-23, Volume: 4

    Topics: Anaerobiosis; Animals; Female; Glucose; Glycolysis; Hypoxia-Inducible Factor 1; Immunoenzyme Techniq

2014
SN38 polymeric nanoparticles: in vitro cytotoxicity and in vivo antitumor efficacy in xenograft balb/c model with breast cancer versus irinotecan.
    International journal of pharmaceutics, 2014, Aug-25, Volume: 471, Issue:1-2

    Topics: Animals; Antineoplastic Agents, Phytogenic; Camptothecin; Cell Line, Tumor; Cell Survival; Drug Carr

2014
Dephosphorylation and biodistribution of 1-¹³C-phospholactate in vivo.
    Journal of labelled compounds & radiopharmaceuticals, 2014, Jun-30, Volume: 57, Issue:8

    Topics: Animals; Carbon Isotopes; Carbon-13 Magnetic Resonance Spectroscopy; Cell Line, Tumor; Contrast Medi

2014
A therapeutic microparticle-based tumor lysate vaccine reduces spontaneous metastases in murine breast cancer.
    The AAPS journal, 2014, Volume: 16, Issue:6

    Topics: Animals; Antigens, Neoplasm; Autoimmunity; Biocompatible Materials; Cancer Vaccines; CD8-Positive T-

2014
Hyperpolarized magnetic resonance spectroscopy for assessing tumor hypoxia.
    Acta oncologica (Stockholm, Sweden), 2015, Volume: 54, Issue:9

    Topics: Administration, Inhalation; Animals; Cell Hypoxia; Female; Lactic Acid; Magnetic Resonance Spectrosc

2015
Disease Subtype-Independent Biomarkers of Breast Cancer Chemoprevention by the Ayurvedic Medicine Phytochemical Withaferin A.
    Journal of the National Cancer Institute, 2017, Volume: 109, Issue:6

    Topics: 8-Hydroxy-2'-Deoxyguanosine; Acetyl Coenzyme A; Aldehyde Dehydrogenase 1 Family; Animals; Apoptosis;

2017
Gpr132 sensing of lactate mediates tumor-macrophage interplay to promote breast cancer metastasis.
    Proceedings of the National Academy of Sciences of the United States of America, 2017, 01-17, Volume: 114, Issue:3

    Topics: Animals; Breast Neoplasms; Cell Adhesion; Cell Cycle Proteins; Cell Line, Tumor; Cell Movement; Fema

2017
The Effect of Chrysin Loaded PLGA-PEG on Metalloproteinase Gene Expression in Mouse 4T1 Tumor Model.
    Drug research, 2017, Volume: 67, Issue:4

    Topics: Animals; Antineoplastic Agents; Breast Neoplasms; Cell Line, Tumor; Cell Proliferation; Drug Carrier

2017
Intratumoral delivery of encapsulated IL-12, IL-18 and TNF-alpha in a model of metastatic breast cancer.
    Breast cancer research and treatment, 2010, Volume: 122, Issue:2

    Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Carcinoma; CD4-Positive T-Lymphocytes; CD8-

2010
Biodistribution of antisense nanoparticles in mammary carcinoma rat model.
    Drug delivery, 2010, Volume: 17, Issue:6

    Topics: Animals; Antineoplastic Agents; Antisense Elements (Genetics); Bone Neoplasms; Carcinoma; Cell Line,

2010
Stereocomplexed poly(lactic acid)-poly(ethylene glycol) nanoparticles with dual-emissive boron dyes for tumor accumulation.
    ACS nano, 2010, Sep-28, Volume: 4, Issue:9

    Topics: Absorption; Animals; Biological Transport; Boron; Coloring Agents; Lactic Acid; Mammary Neoplasms, E

2010
Mitochondrial oxidative stress in cancer-associated fibroblasts drives lactate production, promoting breast cancer tumor growth: understanding the aging and cancer connection.
    Cell cycle (Georgetown, Tex.), 2011, Dec-01, Volume: 10, Issue:23

    Topics: Animals; Breast Neoplasms; Caveolin 1; Cell Line, Tumor; Cellular Senescence; Coculture Techniques;

2011
Lactate detection in inducible and orthotopic Her2/neu mammary gland tumours in mouse models.
    NMR in biomedicine, 2013, Volume: 26, Issue:1

    Topics: Animals; Biomarkers, Tumor; Cell Line, Tumor; Lactic Acid; Mammary Neoplasms, Experimental; Mice; Re

2013
Doxorubicin loaded pH-sensitive polymeric micelles for reversal of resistant MCF-7 tumor.
    Journal of controlled release : official journal of the Controlled Release Society, 2005, Mar-21, Volume: 103, Issue:2

    Topics: Animals; Antibiotics, Antineoplastic; Cell Line, Tumor; Cell Survival; Doxorubicin; Drug Compounding

2005
Spatial heterogeneity and oxygen dependence of glucose consumption in R3230Ac and fibrosarcomas of the Fischer 344 rat.
    Cancer research, 2005, Jun-15, Volume: 65, Issue:12

    Topics: Animals; Blood Glucose; Cell Hypoxia; Female; Fibrosarcoma; Glucose; Lactic Acid; Liver; Mammary Neo

2005
Influence of estradiol on mammary tumor collagen solubility in DMBA-induced rat mammary tumors.
    Cell biology international, 2006, Volume: 30, Issue:2

    Topics: 9,10-Dimethyl-1,2-benzanthracene; Animals; Ascorbic Acid; Collagen; Estradiol; Female; Lactic Acid;

2006
Monitoring metabolite gradients in the blood, liver, and tumor after induced hyperglycemia in rats with R3230 flank tumors using microdialysis and bioluminescence imaging.
    Advances in experimental medicine and biology, 2005, Volume: 566

    Topics: Animals; Blood Glucose; Female; Glucose; Humans; Hyperglycemia; Lactic Acid; Liver; Luminescent Meas

2005
Attenuation of LDH-A expression uncovers a link between glycolysis, mitochondrial physiology, and tumor maintenance.
    Cancer cell, 2006, Volume: 9, Issue:6

    Topics: Adenosine Triphosphate; Animals; Cell Hypoxia; Cell Line, Tumor; Cell Proliferation; Cell Transforma

2006
Liposomal or nanoparticle alpha-TEA reduced 66cl-4 murine mammary cancer burden and metastasis.
    Drug delivery, 2007, Volume: 14, Issue:8

    Topics: Administration, Oral; Animals; Antineoplastic Agents; Apoptosis; Body Weight; Cell Line, Tumor; Fema

2007
Effects of extreme hypoxia on the growth and viability of EMT6/SF mouse tumor cells in vitro.
    Cancer research, 1983, Volume: 43, Issue:8

    Topics: Animals; Cell Cycle; Cell Survival; Cells, Cultured; DNA Replication; Glucose; Hypoxia; Lactates; La

1983
PEG-coated poly(lactic acid) nanoparticles for the delivery of hexadecafluoro zinc phthalocyanine to EMT-6 mouse mammary tumours.
    The Journal of pharmacy and pharmacology, 1995, Volume: 47, Issue:5

    Topics: Animals; Colloids; Delayed-Action Preparations; Emulsions; Glycerol; Indoles; Injections, Intravenou

1995
Metabolic imaging in tumours by means of bioluminescence.
    British journal of cancer, 1995, Volume: 72, Issue:5

    Topics: Adenocarcinoma; Adenosine Triphosphate; Animals; Carcinoma, Squamous Cell; Cell Death; Colorectal Ne

1995
Single-scan in vivo lactate editing with complete lipid and water suppression by selective multiple-quantum-coherence transfer (Sel-MQC) with application to tumors.
    Journal of magnetic resonance. Series B, 1995, Volume: 106, Issue:3

    Topics: Animals; Body Water; Lactates; Lactic Acid; Lipids; Magnetic Resonance Spectroscopy; Mammary Neoplas

1995
Metabolic consequences of a reversed pH gradient in rat tumors.
    Cancer research, 1994, Aug-01, Volume: 54, Issue:15

    Topics: Adenosine Diphosphate; Adenosine Triphosphate; Animals; Carbonates; Cell Membrane Permeability; Hydr

1994
Controlled release low dose medroxyprogesterone acetate (MPA) inhibits the development of mammary tumors induced by dimethyl-benz(a) anthracene in the rat.
    Breast cancer research and treatment, 1993, Volume: 26, Issue:3

    Topics: 9,10-Dimethyl-1,2-benzanthracene; Animals; Chemistry, Pharmaceutical; Delayed-Action Preparations; D

1993
Photodynamic therapy of tumours with hexadecafluoro zinc phthalocynine formulated in PEG-coated poly(lactic acid) nanoparticles.
    International journal of cancer, 1996, Jun-11, Volume: 66, Issue:6

    Topics: Animals; Biodegradation, Environmental; Coloring Agents; Drug Carriers; Emulsions; Glycerol; Indoles

1996
Localized in vivo 1H NMR spectroscopy of murine tumours: effect of blood flow reduction.
    NMR in biomedicine, 1999, Volume: 12, Issue:4

    Topics: Animals; Choline; Hydralazine; Lactic Acid; Magnetic Resonance Spectroscopy; Mammary Neoplasms, Expe

1999
Effects of a controlled-release cisplatin delivery system used after resection of mammary carcinoma in mice.
    American journal of veterinary research, 1999, Volume: 60, Issue:11

    Topics: Animals; Cisplatin; Combined Modality Therapy; Delayed-Action Preparations; Female; Injections, Intr

1999
Effect of changing tumor oxygenation on glycolytic metabolism in a murine C3H mammary carcinoma assessed by in vivo nuclear magnetic resonance spectroscopy.
    Cancer research, 2001, Jul-01, Volume: 61, Issue:13

    Topics: Animals; Blood Glucose; Carbon Dioxide; Carbon Isotopes; Carbon Monoxide; Female; Glucose; Glycolysi

2001
Tissue gradients of energy metabolites mirror oxygen tension gradients in a rat mammary carcinoma model.
    International journal of radiation oncology, biology, physics, 2001, Nov-01, Volume: 51, Issue:3

    Topics: Adenosine Triphosphate; Animals; Cell Hypoxia; Diffusion Chambers, Culture; Glucose; Lactic Acid; Lu

2001
Evaluation of cisplatin in combination with a biologic response modifier in a murine mammary carcinoma model.
    Cancer investigation, 2002, Volume: 20, Issue:4

    Topics: Adenocarcinoma; Adjuvants, Immunologic; Animals; Antineoplastic Agents; Bile; Cisplatin; Delayed-Act

2002
Metabolic imaging in microregions of tumors and normal tissues with bioluminescence and photon counting.
    Journal of the National Cancer Institute, 1988, Aug-03, Volume: 80, Issue:11

    Topics: Adenosine Triphosphate; Animals; Colonic Neoplasms; Female; Glucose; Humans; Lactates; Lactic Acid;

1988